Literature DB >> 8090921

Hepatic metastases and cavernous hemangiomas: distinction with standard- and triple-dose gadoteridol-enhanced MR imaging.

D G Mitchell1, S Saini, J Weinreb, E E De Lange, V M Runge, J E Kuhlman, Y Parisky, C D Johnson, J J Brown, M Schnall.   

Abstract

PURPOSE: To determine if hepatic metastases can be distinguished from cavernous hemangiomas by pattern analysis of magnetic resonance (MR) images obtained prior to and following administration of gadoteridol at standard (0.1 mmol/kg) and triple (0.3 mmol/kg) doses.
MATERIALS AND METHODS: Ninety-five patients with proved hepatic metastases (n = 71) or cavernous hemangiomas (n = 24) underwent MR imaging at 16 different institutions. T2-weighted spin-echo and T1-weighted images were obtained before and after gadoteridol administration. Two independent blinded reviewers rated individual features of benignancy versus malignancy on a five-point confidence scale.
RESULTS: The most useful diagnostic features, with 100% specificity, were nodular enhancement for hemangiomas and rim enhancement for metastases. Confident (definitely benign or definitely malignant) diagnoses were rendered in 80 of 95 cases (84%), with an accuracy of a confident diagnosis of 96%.
CONCLUSION: The pattern of enhancement on T1-weighted images is highly accurate for distinction between hemangiomas and metastases in images obtained with both doses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8090921     DOI: 10.1148/radiology.193.1.8090921

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  14 in total

1.  Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 3 clinical trial.

Authors:  Steven S Raman; Christopher Leary; David A Bluemke; Marco Amendola; Dushyant Sahani; Jeffrey D McTavish; Jeffrey Brody; Eric Outwater; Donald Mitchell; Douglas H Sheafor; Jeff Fidler; Isaac R Francis; Richard C Semelka; Kohkan Shamsi; Simone Gschwend; David R Feldman; Josy Breuer
Journal:  J Comput Assist Tomogr       Date:  2010 Mar-Apr       Impact factor: 1.826

2.  Hepatic fat assessment using advanced Magnetic Resonance Imaging.

Authors:  Yong Pang; Baiying Yu; Xiaoliang Zhang
Journal:  Quant Imaging Med Surg       Date:  2012-09

Review 3.  Approach of the patient with a liver mass.

Authors:  Carlos Rodríguez de Lope; María E Reig; Anna Darnell; Alejandro Forner
Journal:  Frontline Gastroenterol       Date:  2012-08-11

4.  Numerical Analysis of Human Sample Effect on RF Penetration and Liver MR Imaging at Ultrahigh Field.

Authors:  Yong Pang; Bing Wu; Chunsheng Wang; Daniel B Vigneron; Xiaoliang Zhang
Journal:  Concepts Magn Reson Part B Magn Reson Eng       Date:  2011-10       Impact factor: 1.176

5.  A case of atypical caudate lobe hemangioma mimicking hepatocellular carcinoma: CT and angiographic manifestations.

Authors:  Hsin-Chi Chen; Chi-Ming Lee; Ching-Shyang Chen; Chih-Hsiung Wu
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

6.  Contributions of Magnetic Resonance Imaging to Gastroenterological Practice: MRIs for GIs.

Authors:  Christopher G Roth; Dina Halegoua-De Marzio; Flavius F Guglielmo
Journal:  Dig Dis Sci       Date:  2018-05       Impact factor: 3.199

Review 7.  Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions.

Authors:  Ahmed Ba-Ssalamah; Martin Uffmann; Sanjai Saini; Nina Bastati; Christian Herold; Wolfgang Schima
Journal:  Eur Radiol       Date:  2008-09-23       Impact factor: 5.315

8.  MRI characterization of 124 CT-indeterminate focal hepatic lesions: evaluation of clinical utility.

Authors:  Khaled M Elsayes; John R Leyendecker; Christine O Menias; Erica P Oliveira; Vamsidhar R Narra; William C Chapman; Moataz H Hassanien; Mohamed S Elsharkawy; Jeffrey J Brown
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

9.  Dynamic evolutionary changes in blood flow measured by MDCT in a hepatic VX2 tumor implant over an extended 28-day growth period: time-density curve analysis.

Authors:  Hanping Wu; Agata A Exner; Hong Shi; Joshua Bear; John R Haaga
Journal:  Acad Radiol       Date:  2009-12       Impact factor: 3.173

Review 10.  Distinguishing benign from malignant liver tumours.

Authors:  Jay P Heiken
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.